2005.09-2009.07   吉林大學, 藥物制劑, 學士學位

2011.09-2016.07   上海藥物研究所, 藥理學（碩博）, 理學博士學位

2016.08-2021.03   上海藥物研究所, 先后博士后，副研究員

2021.04-2022.04   山東大學，研究員（齊魯青年學者）

2022.05-至今 中國科學院青島生物能源與過程研究所，研究員

已發表SCI論文：

1. Huahao Shen#…Songmin Ying*, Honglei Ma*, and Yan Zhang*, Huahao Shen*(2022). Molecular insights into ligand recognition and activation of chemokine receptors CCR2 and CCR3. Cell Discovery, (2022) 8:44

2. Zhaotong Cong#, Li-Nan Chen#, Honglei Ma#, Qingtong Zhou#… Dehua Yang*, H. Eric Xu*, Yan Zhang*&Ming-Wei Wang*(2021). Molecular insights into ago-allosteric modulation of the human glucagon-like peptide-1 receptor. Nature. Communications. 12(3763)

3. Honglei Ma#,…Daopeng Yuan* & H. Eric Xu*(2020）. Structural insights into the activation of GLP-1R by a small molecule agonist. Cell Research. 0:1–3

4. Honglei Ma* …H. Eric Xu*,Jiayang Li* and Karsten Melcher*(2017). A D53 repression motif induces oligomerization of TOPLESS corepressors and promotes assembly of a corepressor-nucleosome complex. Science Advances. 2017.6.01,3(6)

5. Jiyuan Ke#, Honglei Ma#…H Eric Xu* and Karsten Melcher* (2015). Structural basis for recognition of diverse transcriptional repressors by the TOPLESS family of corepressors. Science Advances. 2015.7.01,1(6)

聯系方式：

mahonglei@qibebt.ac.cn